@unpublished{HocherReichetzeder2013,
  author    = {Hocher, Berthold and Reichetzeder, Christoph},
  title     = {Vitamin D and cardiovascular risk in postmenopausal women how to translate preclinical evidence into benefit for patients},
  series = {Kidney international : official journal of the International Society of Nephrology},
  volume    = {84},
  journal   = {Kidney international : official journal of the International Society of Nephrology},
  number    = {1},
  publisher = {Nature Publ. Group},
  address   = {New York},
  issn      = {0085-2538},
  doi       = {10.1038/ki.2013.139},
  pages     = {9 -- 11},
  year      = {2013},
  abstract  = {Preclinical work indicates that calcitriol restores vascular function by normalizing the endothelial expression of cyclooxygenase-2 and thromboxane-prostanoid receptors in conditions of estrogen deficiency and thus prevents the thromboxane-prostanoid receptor activation-induced inhibition of nitric oxide synthase. Since endothelial dysfunction is a key factor in the pathogenesis of cardiovascular diseases, this finding may have an important translational impact. It provides a clear rationale to use endothelial function in clinical trials aiming to find the optimal dose of vitamin D for the prevention of cardiovascular events in postmenopausal women.},
  language  = {en}
}